The global surgical microscope market size was valued at USD 928.6 million in 2019 and is expected to expand at a compound annual growth rate (CAGR) of 10.9% from 2020 to 2027. Complex minimally invasive neurosurgery and ENT procedures demand more precision from the surgeons performing the operations. With the advent of these microscopes, it became easier for surgeons to perform such procedures more accurately in less time, thus driving the market. The introduction of technologically-advanced products is driving the demand for surgical microscopes as they are more precise, offer better illumination sources, and provide options for customization and technology integration based on the complexity of the procedures. Emerging technologies such as wide-angle illumination, red reflex illumination, and automation and augmented reality microscopy are expected to boost the market growth. International players such as Carl Zeiss Meditec AG and Leica Microsystems are contributing to the market growth by providing highly advanced automated and robotic surgical microscopes for more precision.
Surgical microscopes have become an essential tool for minimally invasive surgical procedures in several fields, including neurosurgery, ophthalmic surgery, dental surgery, otorhinolaryngology, and cosmetic surgery. Technological advancements in the product have significantly improved vision, stability, sizing, positioning, and recording capabilities as well as helped in the integration of image-guided microscope systems for better outcomes.
They offer 3D visualization, optimum lighting, and magnification of deep surgical fields through small approaches. Apart from clinical benefits, surgeons physically benefit from these microscopes as they allow them to adjust their posture while performing long and complicated procedures. These factors are anticipated to further propel the market growth during the forecast period.
According to the statement released by Carl Zeiss in March 2020, the company has discontinued all the internal and external events and is operational via video conferences. But it assured all its customers that there will be no delay in the deliveries of the orders as the company has developed comprehensive measures to protect all of its employees and maintain smart business continuity. The company is following all the government measures to maintain production in its plants. The company is closely monitoring its supply chains and secured distribution channels.
Companies reported decreases in the revenue of the second quarter for the year 2020 due to the impact of the COVID-19 pandemic, which affected the supply chain of most of the companies. Currently, most of the companies have resumed their businesses and are delivering orders within the given guidelines.
On-casters microscopes held the largest share of 79.5% in 2019 and are anticipated to expand at the highest CAGR over the forecast period. On-casters microscopes are floor-mounted devices that have retractable casters with single, double, or compound wheels. The caster is specifically designed to provide absolute equilibrium, allowing free movement of the balanced microscope. Caster-mounted microscopes should be properly fixed and positioned with the operating bed. They also have top and down movement controls for adjusting the height of the device.
The base of this microscope is designed in a way that it does not interfere with foot controls or power cables. Mounting on wheels provide users with portability and flexibility capabilities. Caster-mounted microscopes are versatile and easy to clean and can maintain sterility in the operating room. Advantages such as effective maneuvering and repositioning functionality requiring minimum efforts offered by these microscopes help in reducing the duration of the operation.
The end-use segment of the market includes hospital and physician clinics and other settings. The hospital segment dominated the market and held a 59.4% share of the overall revenue in 2019 owing to the higher number of patient admissions and surgeries performed in hospitals and greater financing capabilities.
The physician/dentist clinics and other settings segment is expected to grow at a significant rate over the forecast period. The availability of smaller operational microscopes and the growing field of dentistry are among the factors contributing to the growth of this segment.
Key application segments include neurosurgery and spine surgery, ENT surgery, dentistry, gynecology, urology, ophthalmology, plastic and reconstructive surgeries, and others. The ophthalmology segment held the largest revenue share of 37.3% in 2019. Neurosurgery and spine surgery was one of the major segments in 2019. The rising prevalence of brain disorders as well as the complexity of their treatment have led to the adoption of advanced techniques that involve the use of surgical microscopes.
The ENT surgery segment is expected to grow at a lucrative rate over the forecast period. The dentistry and plastic and reconstructive surgeries segments are also expected to grow at a significant rate in the years to come owing to the rising demand for cosmetic dentistry and an increase in the volume of reconstructive surgeries. ENT surgical microscopes are customizable using tubes, objective lenses, stands, handles, and other parts.
Zeiss has an exhaustive portfolio of products for treating otorhinolaryngology disorders. Recently, in 2018, Zeiss launched its new product named EXTARO 300 with Advanced Visualization System TIVATO for complex procedures. A South Korean company named Chammed Co. Ltd. manufactures ENT equipment and offers surgical microscopes for ENT surgeries.
North America dominated the global market in 2019 with a share of 39.9%. This is attributed to the presence of sophisticated facilities, highly advanced equipment, skilled neurosurgeons and cosmetic surgeons, rising number of surgical facilities, preference for outpatient settings, and supportive reimbursement framework for medical treatments. Moreover, the prevalence of ophthalmic and neurologic disorders in this region is substantially higher, which is facilitating the regional market growth.
Asia Pacific is anticipated to witness the fastest growth over the forecast period. High incidence of ophthalmic disorders, growing medical tourism, and the rising number of surgeries in inpatient and outpatient settings are among the major factors driving the market in the region. In addition, favorable government policies to improve the healthcare system and rapid economic development in many countries of the region are some of the factors anticipated to boost the market growth over the forecast period.
New product launches, collaboration with hospitals and surgical centers for product installation, and mergers and acquisitions for product portfolio enhancement and geographical expansion are some of the strategies being adopted by key players of the market. For instance, in March 2020, Carl Zeiss acquired Saxonia Systems AG, a customized software solution provider. The acquired company now operates as Carl Zeiss Digital Innovation, offering customized software solutions to the customers.
In February 2019, Carl Zeiss Meditec AG along with the Christoffel Mission for the Blind (CBM) opened a training center in Pune, India for treating cataracts, in collaboration with the Poona Blind Men’s Association (PBMA). In October 2018, the company announced the acquisition of IanTECH, Inc., a privately held company focused on technologies for micro-interventional cataract procedures. This acquisition enhanced the company’s portfolio of ophthalmic solutions. Some prominent players in the global surgical microscope market include:
Carl Zeiss Meditec AG
Leica Microsystems
Olympus Corporation
Haag-Streit Surgical GmbH
Synaptive Medical
Alcon, Inc. (Novartis)
Topcon Corporation
ARI Medical Technology Co., Ltd.
Takagi Seiko Co., Ltd.
Seiler Instrument Inc.
Chammed Co. Ltd.
Report Attribute |
Details |
Market size value in 2020 |
USD 1.0 billion |
Revenue forecast in 2027 |
USD 2.1 billion |
Growth Rate |
CAGR of 10.9% from 2020 to 2027 |
Base year for estimation |
2019 |
Historical data |
2016 - 2018 |
Forecast period |
2020 - 2027 |
Quantitative units |
Revenue in USD million/billion and CAGR from 2020 to 2027 |
Report coverage |
Revenue forecast, company ranking, competitive landscape, growth factors, and trends |
Segments covered |
Type, application, end use, region |
Regional scope |
North America; Europe; Asia Pacific; Latin America; MEA |
Country scope |
U.S.; Canada; U.K.; Germany; China; Japan; Mexico; Brazil; South Africa |
Key companies profiled |
Carl Zeiss Meditec AG; Leica Microsystems; Olympus Corporation; Haag-Streit Surgical GmbH; Synaptive Medical; Alcon, Inc. (Novartis); Topcon Corporation; ARI Medical Technology Co., Ltd.; Takagi Seiko Co., Ltd.; Seiler Instrument Inc.; Chammed Co. Ltd. |
Customization scope |
Free report customization (equivalent up to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope. |
Pricing and purchase options |
Avail customized purchase options to meet your exact research needs. Explore purchase options |
This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends and opportunities in each of the sub-segments from 2016 to 2027. For the purpose of this study, Grand View Research has segmented the global surgical microscopes market report based on type, application, end use, and region:
Type Outlook (Revenue, USD Million, 2016 - 2027)
On Casters
Wall Mounted
Table Top
Ceiling Mounted
Application Outlook (Revenue, USD Million, 2016 - 2027)
Ophthalmology
Neurosurgery and Spine Surgery
ENT Surgery
Dentistry
Plastic & Reconstructive Surgeries
Gynecology
Urology
Other Surgeries
End-use Outlook (Revenue, USD Million, 2016 - 2027)
Hospital
Physician Clinics and Other Settings
Regional Outlook (Revenue, USD Million, 2016 - 2027)
North America
U.S.
Canada
Europe
U.K.
Germany
Asia Pacific
Japan
China
Latin America
Brazil
Mexico
Middle East & Africa
South Africa
b. Some key players operating in the surgical microscopes market include Carl Zeiss Meditec AG; Leica Microsystems; Haag-Streit Surgical GmbH; Synaptive Medical, Alcon, Inc. (Novartis); Olympus Corporation; Topcon Corporation; ARI Medical Technology Co., Ltd.; Takagi Seiko Co., Ltd.; Seiler Instrument Inc.; and Chammed Co. Ltd.
b. Key factors that are driving the surgical microscopes market growth include increasing demand for complex minimally invasive neurosurgery and ENT procedures and the introduction of technologically-advanced products.
b. The global surgical microscopes market size was estimated at USD 928.6 million in 2019 and is expected to reach USD 1.0 billion in 2020.
b. The global surgical microscopes market is expected to grow at a compound annual growth rate of 10.9% from 2020 to 2027 to reach USD 2.1 billion by 2027
b. North America dominated the surgical microscopes market in 2019. This is due to the presence of sophisticated facilities, highly advanced equipment, skilled neuro, and cosmetic surgeons, a rising number of surgical facilities, a preference for outpatient settings, and a supportive reimbursement framework for medical treatments.
This report has a service guarantee. We stand by our report quality.
We are in compliance with GDPR & CCPR norms. All interactions are confidential.
Design an exclusive study to serve your research needs.
Get your queries resolved from an industry expert.
"The quality of research they have done for us has been excellent..."
Amongst the majorly used Covid-19 screening options, imaging is preferred by most healthcare professionals as it provides a primary diagnosis in a short time. All the imaging modalities including nuclear imaging have been used exhaustively to study Covid-19 and its effect on different patients in each demography. These are used in theories such as comparison of the vulnerability of pediatric and geriatric patients, and treatment response for several drug combinations. The rising requirement for advanced lung imaging solutions is expected to boost the development studies for lung phantoms. A detailed study on lung deterioration in Covid-19 patients is expected to provide advanced measures for early detection of the disease. The report will account for Covid19 as a key market contributor.